The R&D heads of over 25 global biopharmaceutical companies have signed a joint letter expressing alarm over the impact of the Biden administration's new prescription medicine price negotiation power. …
Global R&D heads sign joint letter expressing alarm over new pricing power
October 20, 2023 Latest NewsBioPharmaNews of the Day
Latest Video
Georgia Forrest
New Stories
-
The 'Dispatched' Week in Review Podcast - 6 February
February 6, 2026 - - Podcast -
AI in healthcare and why doing nothing might be the biggest risk
February 5, 2026 - - Latest News -
An effective example of making the case for reform in a status quo-biased system
February 5, 2026 - - Latest News -
Pharmac consults on expanding access to Takeda blood cancer therapy
February 5, 2026 - - Latest News -
GBMA moves to reclaim the reform agenda with a focus on pricing and supply
February 5, 2026 - - Latest News -
Nuclear medicine sector argues for dedicated scheme to unlock cancer therapies
February 4, 2026 - - Latest News -
Pfizer’s once-monthly weight-loss injection delivers strong mid-stage results
February 4, 2026 - - Latest News